Cinqaero conc perf 25 mg/2.5 ml, , Cinqaero conc perf 25 mg/2.5 ml flac 2.5 ml
7680663400022
CH-66340
R03DX08
1 / 3
google
Details
- Product number
- 6634002
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Cinqaero 25 mg/2,5 mL, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
reslizumabum
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
saccharum
|
- | Substance | HNIDK |
|
natrii acetas trihydricus
|
- | Substance | HNIDK |
|
acidum aceticum glaciale
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
0.35 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 155.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/10/2018
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66340
- Drug name
- Cinqaero, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- R03DX08
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 09/11/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 03.04.5.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CINQAERO conc perf 25 mg/2.5ml flac 2.5 ml
- Description (DE)
- CINQAERO Inf Konz 25 mg/2.5ml Durchstf 2.5 ml
- Market launch
- 12/07/2018
- Market withdrawal
- 13/03/2026
- Narcotic (BTM)
- No